Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021

Rhea-AI Summary

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company, will report its third quarter 2021 financial results on November 8, 2021. The management team will hold a live conference call at 4:15 p.m. ET to discuss financial results and provide a corporate update. Interested parties can join via domestic and international dial-in numbers or through a live webcast. A replay will be available for 30 days on Gossamer's website, ensuring accessibility for investors and stakeholders.

SAN DIEGO--(BUSINESS WIRE)-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its third quarter 2021 financial results on Monday, November 8, 2021.

In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:15 p.m. ET on Monday, November 8, 2021, to discuss the Company’s financial results and provide a corporate update.

Conference ID: 9749597
Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782
Live Webcast: https://edge.media-server.com/mmc/p/sezfo9jk

A replay of the audio webcast will be available for 30 days on the Investors section of the Company's website, www.gossamerbio.com.

About Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211102006184/en/

For Investors and Media:

Bryan Giraudo, Chief Operating Officer & Chief Financial Officer

Gossamer Bio Investor Relations

ir@gossamerbio.com

Source: Gossamer Bio, Inc.

FAQ

When will Gossamer Bio report its third quarter 2021 financial results?

Gossamer Bio will report its third quarter 2021 financial results on November 8, 2021.

What time is the Gossamer Bio earnings call scheduled?

The Gossamer Bio earnings call is scheduled for 4:15 p.m. ET on November 8, 2021.

How can I access the Gossamer Bio earnings call?

You can access the Gossamer Bio earnings call via domestic and international dial-in numbers or through a live webcast.

Will there be a replay of the Gossamer Bio earnings call?

Yes, a replay of the Gossamer Bio earnings call will be available for 30 days on their website.